Formulation and Evaluation of Nitrendipine Buccal Films
2008

Nitrendipine Buccal Films

publication Evidence: moderate

Author Information

Author(s): Nappinnai M., Chandanbala R., Balaijirajan R.

Primary Institution: C. L. Baid Mehta College of Pharmacy

Hypothesis

Buccal delivery of nitrendipine may circumvent hepatic first pass metabolism to improve its bioavailability.

Conclusion

The best formulation for buccal delivery of nitrendipine was found to be F-4, which showed moderate drug release and satisfactory film characteristics.

Supporting Evidence

  • The buccal route offers advantages like avoiding first pass metabolism and controlled drug delivery.
  • Nitrendipine has low oral bioavailability and extensive hepatic metabolism.
  • Formulation F-4 showed moderate drug release of 50% at the end of 2 hours.

Takeaway

The study created a special film to deliver a medicine called nitrendipine through the mouth, which can help the body use the medicine better.

Methodology

The study involved formulating mucoadhesive buccal films using various polymers and evaluating their physicochemical properties and drug release characteristics.

Digital Object Identifier (DOI)

10.4103/0250-474X.45402

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication